22,930 results match your criteria Mitral Stenosis


[A strategic roadmap of the Italian Society of Interventional Cardiology (SICI-GISE) to ensure patient's access to appropriate treatment].

G Ital Cardiol (Rome) 2019 Apr;20(4):4-19

A.O. Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna.

In comparison with the international scenario, in Italy the penetration of several important scientific and technological innovations in the field of cardiovascular intervention appears to be inadequate both in terms of number of patients treated with respect to the actual need, and inhomogeneity between the different geographical areas of the country. One of the main institutional objectives of the Italian Society of Interventional Cardiology (SICI-GISE) is to develop a roadmap to guarantee homogeneous access throughout the whole national territory to treatments that are recommended by the major international guidelines. The present document focuses on four main areas of cardiovascular intervention: (i) transcatheter treatment of aortic valve stenosis, (ii) percutaneous mitral valve repair, (iii) prevention of cardioembolic stroke through percutaneous left atrial appendage occlusion in patients with non-valvular atrial fibrillation, (iv) optimization of coronary revascularization with the aid of the functional study of coronary lesions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3146.31274DOI Listing

Prognostic Value of Left Atrial Volume in Patients with Progressive Mitral Stenosis: A Possible Analogy with Left Ventricular Mass in the Setting of Pressure Overload.

Authors:
Jun Bean Park

J Cardiovasc Imaging 2019 Apr;27(2):134-136

Division of Cardiology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4250/jcvi.2019.27.e23DOI Listing

Prognostic Implications of the Left Atrial Volume Index in Patients with Progressive Mitral Stenosis.

J Cardiovasc Imaging 2019 Apr;27(2):122-133

Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.

Background: Limited data are available on the prognosis of progressive mitral stenosis (MS). We evaluated the factors associated with adverse events in patients with progressive MS.

Methods: We retrospectively analyzed 259 consecutive patients with pure progressive MS with a mitral valve area (MVA) between 1. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4250/jcvi.2019.27.e20DOI Listing

One Hundred and Counting: Dr. Dwight C. McGoon's Enduring Legacy.

Ann Thorac Surg 2019 Apr 12. Epub 2019 Apr 12.

Department of Cardiovascular Surgery, Mayo Clinic, 200 First St SW, Rochester, Minnesota 55905.

Dr. Dwight C. McGoon, a prolific surgeon at the Mayo Clinic, achieved an amazing feat during the early days of cardiac surgery. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2019.02.073DOI Listing
April 2019
1 Read

Comparative effectiveness, safety, and costs of rivaroxaban and warfarin among morbidly obese patients with atrial fibrillation.

Am Heart J 2019 Feb 20;212:113-119. Epub 2019 Feb 20.

Department of Medicine, Anticoagulation and Clinical Thrombosis Services, Northwell Health System, The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY.

Background: There are limited data regarding clinical outcomes and healthcare resource utilization of direct oral anticoagulants (DOACs) in patients with atrial fibrillation (AF) who are morbidly obese (body mass index >40 kg/m or body weight >120 kg).

Methods: Using data from 2 US healthcare claims databases, we identified patients initiating rivaroxaban or warfarin who had ≥1 medical claim with an AF diagnosis, a diagnostic code for morbid obesity (ICD-9: 278.01, V85. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2019.02.001DOI Listing
February 2019

Yellow nail syndrome resulting from cardiac mitral valve replacement.

J Cardiothorac Surg 2019 Apr 11;14(1):72. Epub 2019 Apr 11.

Department in cardiac surgery hospital of Damascus university, Damascus, Syria.

Background: Yellow nail syndrome is a rare disease with unknown etiology, Attributed to functional anomalies or disturbance in lymphatic drainage. This condition is characterized by triad of nail discoloration, respiratory or intrathoracic manifestations and lymphedema.

Case Presentation: Twenty days after mitral valve replacement for severe rheumatic mitral valve stenosis, 39 years old woman presented with face tenderness and hearing problems besides stuffy and clogged nose and underwent routin rhinosinusitis therapy. Read More

View Article

Download full-text PDF

Source
https://cardiothoracicsurgery.biomedcentral.com/articles/10.
Publisher Site
http://dx.doi.org/10.1186/s13019-019-0903-1DOI Listing
April 2019
6 Reads

Impact of moderate to severe mitral stenosis in patients undergoing transcatheter aortic valve replacement.

Int J Cardiol 2019 Mar 28. Epub 2019 Mar 28.

Quebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada. Electronic address:

Objective: In patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR), the impact of concomitant mitral stenosis (MS) remains unknown. The aim of this study was to determine the incidence and impact of moderate to severe MS in patients undergoing TAVR.

Methods: The study included 2113 consecutive patients (mean age: 80 ± 9 years, mean STS: 6. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2019.03.053DOI Listing
March 2019
1 Read

Current status and future perspective of structural heart disease intervention.

J Cardiol 2019 Apr 5. Epub 2019 Apr 5.

Heart Center Bonn, Department of Medicine II, University Hospital Bonn, Germany. Electronic address:

Valvular heart diseases are one of the most frequent causes for heart failure. Degenerative diseases of the aortic and mitral valve as well as a dysfunctional tricuspid valve disease result in a worse clinical outcome if severe. Minimal-invasive, surgical and/or catheter-based structural heart disease (SHD) interventions have recently seen a dramatic increase. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09145087193008
Publisher Site
http://dx.doi.org/10.1016/j.jjcc.2019.02.022DOI Listing
April 2019
3 Reads

Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?

Clin Res Cardiol 2019 Apr 5. Epub 2019 Apr 5.

Department of Cardiology, Angiology and Respiratory Medicine, Amyloidosis Center, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.

Background: Carpal tunnel syndrome (CTS) and spinal canal stenosis can be frequently observed in the medical history of patients with transthyretin amyloidosis (ATTR), both in the hereditary (mt-ATTR) and wild-type (wt-ATTR) form. The aim of this retrospective single-center analysis was to determine the prevalence of these findings, delay to diagnosis of systemic amyloidosis and the prognostic value in a large cohort of patients with wt-ATTR and mt-ATTR amyloidosis.

Methods: Medical records of 253 patients diagnosed with wt-ATTR, 136 patients with mt-ATTR and 77 asymptomatic gene carriers were screened for history of CTS and spinal canal stenosis and laboratory analysis, electrocardiography and echocardiographic results, respectively. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00392-019-01467-1DOI Listing
April 2019
1 Read

[Mitral valve pathologies].

MMW Fortschr Med 2019 Apr;161(6):46-49

Medizinische Universität Wien, Universitätsklinik für Innere Medizin II/Abteilung Kardiologie, Währinger Gürtel 18-20, A-1090, Wien, Österreich.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s15006-019-0359-1DOI Listing
April 2019
2 Reads

Disturbed energy and amino acid metabolism with their diagnostic potential in mitral valve disease revealed by untargeted plasma metabolic profiling.

Metabolomics 2019 Apr 1;15(4):57. Epub 2019 Apr 1.

Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Ave., Wuhan, 430030, China.

Introduction: Mitral valve disease (MVD), including mitral valve regurgitation (MR) and mitral valve stenosis (MS), is a chronic and progressive cardiac malady. However, the metabolic alterations in MVD is not well-understood till now. The current gold standard diagnostic test, transthoracic echocardiography, has limitations on high-throughput measurement and lacks molecular information for early diagnosis of the disease. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11306-019-1518-1DOI Listing
April 2019
2 Reads

Cardiac risk prediction model for pregnant women with structural heart disease in eastern China.

Int J Gynaecol Obstet 2019 Apr 1. Epub 2019 Apr 1.

Shanghai Obstetrical Cardiology Intensive Care Center, Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.

Objective: To develop a model for predicting cardiac risk among pregnant women with structural heart disease in eastern China.

Methods: The model was built using data from pregnant women (development cohort, n=566; validation cohort, n=314) who delivered at Shanghai Obstetrical Cardiology Intensive Care Center, Renji Hospital, Shanghai, between 2002 and 2015. Independent predictors of adverse cardiac events were determined by logistic regression. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijgo.12820DOI Listing
April 2019
1 Read

Mitral Annular Calcification and Calcific Mitral Stenosis: Therapeutic Challenges and Considerations.

Curr Treat Options Cardiovasc Med 2019 Mar 30;21(4):19. Epub 2019 Mar 30.

Cardiac Ultrasound Laboratory, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Yawkey 5E, Boston, MA, 02114, USA.

Purpose Of Review: Mitral annular calcification (MAC) and associated calcific mitral stenosis (MS) are frequent in the aging population, although optimal management remains debated and outcomes are poor. This article summarizes challenges in the diagnosis and therapy of calcific MS, the indications for valve intervention, procedural concerns, and emerging treatment options.

Recent Findings: Surgical mitral valve replacement is the procedure of choice in symptomatic patients at acceptable surgical risk, with transcatheter mitral valve replacement (TMVR) being evaluated in clinical trials as an alternative for patients at prohibitive surgical risk. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11936-019-0723-6
Publisher Site
http://dx.doi.org/10.1007/s11936-019-0723-6DOI Listing
March 2019
5 Reads

Prevalence of extra-appendage thrombosis in non-valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: a large Transeophageal Echo study.

EuroIntervention 2019 Mar 26. Epub 2019 Mar 26.

Cardiological Department, Misericordia Hospital, Italy.

Aims: Aim of our study was to evaluate the prevalence of left atrial cavity and appendage thrombosis in patients undergoing cardioversion for non-valvular atrial tachyarrhythmias. In persistent atrial tachyarrhythmias 90% of Thrombosis are reported to be located inside the Left Atrial Appendage. This prevalence refers to old studies and metanalysis in mixed population of valvular and non-valvular atrial fibrillation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-19-00128DOI Listing
March 2019
6 Reads

Cardiac findings and hemodynamic changes associated with severe lower urinary tract obstruction in utero.

Ultrasound Obstet Gynecol 2019 Mar 25. Epub 2019 Mar 25.

Department of Pediatrics, Division of Pediatric Cardiology, Columbia University Medical Center, New York-Presbyterian Hospital, New York, NY.

Introduction: Lower urinary tract obstruction (LUTO) in the fetus may result in massive bladder distention, renal dysfunction, oligohydramnios, and lung hypoplasia. The hemodynamic impact of this pathophysiology has not been well-described.

Methods: We included fetuses diagnosed with severe LUTO with giant bladder and with at least one fetal echocardiogram performed at our center from January 2005 to May 2018. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/uog.20271
Publisher Site
http://dx.doi.org/10.1002/uog.20271DOI Listing
March 2019
4 Reads

Mitral valve stenosis after transcatheter aortic valve replacement: Case report and review of the literature.

Cardiovasc Revasc Med 2019 Mar 1. Epub 2019 Mar 1.

Interventional Cardiology Unit, Cardio Center, Humanitas Research Hospital, Rozzano-Milano, Italy.

Mitral stenosis is a rare and potentially severe complication of transcatheter aortic valve replacement (TAVR). Given the anatomic coupling and interdependence of the aortic and mitral valves, it comes by itself that procedures (either surgical or percutaneous) involving the aortic valve imply the risk of altering mitral valve function. Indeed, transcatheter aortic prostheses may impair adequate anterior mitral leaflet (AML) opening, especially when implanted in a "low" position, thus resulting in high transvalvular gradients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2019.02.023DOI Listing
March 2019
1 Read

Concomitant ablation of atrial fibrillation in rheumatic mitral valve surgery.

J Thorac Cardiovasc Surg 2019 Apr 3;157(4):1519-1528.e5. Epub 2018 Oct 3.

Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Electronic address:

Objective: Efficacy of atrial fibrillation ablation in rheumatic mitral valve disease has been regarded inferior to that in nonrheumatic diseases. This study aimed to evaluate net clinical benefits by the addition of concomitant atrial fibrillation ablation in rheumatic mitral valve surgery.

Methods: Among 1229 consecutive patients with atrial fibrillation from 1997 to 2016 (54. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2018.09.023DOI Listing
April 2019
1 Read

A man with fever and breathlessness.

BMJ 2019 Mar 21;364:l1085. Epub 2019 Mar 21.

Royal Bolton Hospital, Bolton, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmj.l1085DOI Listing
March 2019
3 Reads

A Novel Sizing Technique for Mitral Annuloplasty.

Ann Thorac Cardiovasc Surg 2019 Mar 19. Epub 2019 Mar 19.

Department of Cardiovascular Surgery, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Hyogo, Japan.

Although sizing for mitral annuloplasty (MAP) is a critical part of mitral valve repair, no consistent method is used, and precise size adjustment is done somewhat by intuition. We developed a new original ring size tester and have been applying it to our mitral valve repair procedure. The concept is that the tester shapes the annulus into exactly the same size and form as the target annuloplasty while confirming a good leaflet coaptation with a saline test to simulate annuloplasty. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5761/atcs.nm.19-00003DOI Listing
March 2019
2 Reads

Risk factors for residual mitral regurgitation after aortic valve replacement in patients with severe aortic valve stenosis and moderate mitral regurgitation.

Gen Thorac Cardiovasc Surg 2019 Mar 15. Epub 2019 Mar 15.

Department of Cardiovascular and Thoracic Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-Ku, Sapporo, 060-8638, Japan.

Objectives: While it was reported that patients with residual moderate mitral regurgitation (MR) after surgical aortic valve replacement (SAVR) had a poorer prognosis than those without it, the risk factors for residual MR have not been fully elucidated. The aim of the study was to evaluate risk factors for residual MR after SAVR.

Methods: Of the 222 patients who underwent isolated SAVR from 2001 to 2018, 33 (11 men; age: 74 ± 7 years) had functional moderate MR before surgery. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11748-019-01110-wDOI Listing
March 2019
2 Reads

DOACs in Patients With Mitral Stenosis and Atrial Fibrillation: Time for a Randomized Clinical Trial.

J Am Coll Cardiol 2019 Mar;73(10):1132-1134

Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2018.12.048DOI Listing
March 2019
3 Reads

Outcomes of Direct Oral Anticoagulants in Patients With Mitral Stenosis.

J Am Coll Cardiol 2019 Mar;73(10):1123-1131

Division of Cardiology, Department of Internal Medicine, St. Paul's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.

Background: Patients with mitral stenosis and atrial fibrillation (AF) require anticoagulation for stroke prevention. Thus far, all studies on direct oral anticoagulants (DOACs) have excluded patients with moderate to severe mitral stenosis.

Objectives: The aim of this study was to validate the efficacy of DOACs in patients with mitral stenosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2018.12.047DOI Listing
March 2019
3 Reads

Percutaneous endovascular treatment of an iatrogenic superior cava vein syndrome during the immediate post-operative period after mitral-aortic valve replacement.

Rev Esp Anestesiol Reanim 2019 Mar 9. Epub 2019 Mar 9.

Servicio de Anestesiología y Reanimación, Hospital Universitario de Santiago de Compostela, Santiago de Compostela, La Coruña, España.

Superior vena cava syndrome (SVCS) results from superior vena cava obstruction, causing a decrease in venous return from the head, neck, and upper extremities. Although the most frequent cause is still malignant tumour processes, in recent years an increase has been observed in non-tumour causes, such as thrombosis of intravascular devices or iatrogenic causes during cardiac surgery. A case is presented of SVCS after cardiac surgery treated satisfactorily by an endovascular technique and systemic anticoagulation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.redar.2019.01.009DOI Listing
March 2019
1 Read

Heart valve injury due to radiation therapy.

Kardiologiia 2019 Mar 7;59(2S):56-68. Epub 2019 Mar 7.

I. M. Sechenov First Moscow State Medical University (Sechenov University)..

Relevance: Radiation therapy (RT) plays an important role in oncology, improving the immediate and long-term results of treatment of a number of tumors. One of the most significant complications of RT are lesions of the heart valves.

Objective: To study the variants of valve damage that occur in patients who received radiation therapy for cancer. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18087/cardio.2656DOI Listing
March 2019
1 Read

Patient-specific computer simulation for transcatheter cardiac interventions: what a clinician needs to know.

Heart 2019 Mar;105(Suppl 2):s21-s27

Department of Cardiology, Guy's and St Thomas' NHS Foundation Trust London, London, UK.

Patient-specific computer simulation consists of the assessment of the interaction of the device with the host based on the integration of the detailed geometric and biomechanical properties of the device and host. Hence, it allows the prediction of valve performance (efficacy) and complications (safety) and may consequently help the physician to select the valve/device that best fits the individual patient, thereby improving outcome. There is currently little awareness and information in clinical medicine on patient-specific computer simulation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/heartjnl-2018-313514DOI Listing
March 2019
1 Read

Association Between Transthoracic Echocardiography Appropriateness and Echocardiographic Findings.

J Am Soc Echocardiogr 2019 Mar 4. Epub 2019 Mar 4.

Women's College Hospital, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada. Electronic address:

Background: The association between appropriate use criteria and echocardiographic findings in patients with chronic cardiovascular diseases is unknown.

Methods: As a substudy of the Echo WISELY (Will Inappropriate Scenarios for Echocardiography Lessen Significantly) trial, 9,230 transthoracic echocardiographic (TTE) examinations from six Ontario academic hospitals were linked to a registry of echocardiographic findings. The TTE studies were rated appropriate), rarely appropriate, or may be appropriate according to the 2011 appropriate use criteria. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.echo.2019.01.004DOI Listing
March 2019
1 Read

von Willebrand Factor and Management of Heart Valve Disease: JACC Review Topic of the Week.

J Am Coll Cardiol 2019 Mar;73(9):1078-1088

CHU Lille, Université de Lille, Inserm U1011 - EGID, Institut Pasteur de Lille, Lille, France; CHU Lille, Hematology and Transfusion, Lille, France. Electronic address:

For decades, numerous observations have shown an intimate relationship between von Willebrand factor (VWF) multimer profile and heart valve diseases (HVD). The current knowledge of the unique biophysical properties of VWF helps us to understand the longstanding observations concerning the bleeding complications in patients with severe HVD. Not only does the analysis of the VWF multimer profile provide an excellent evaluation of HVD severity, it is also a strong predictor of clinical events. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2018.12.045DOI Listing
March 2019
4 Reads

Is mitral valve disease treated differently in men and women?

Eur J Prev Cardiol 2019 Mar 4:2047487319833307. Epub 2019 Mar 4.

Northwestern University Feinberg School of Medicine, Bluhm Cardiovascular Institute, Chicago, IL, USA.

Purpose: This study was performed to determine if there is a sex-based bias in referral practices, complexity of disease, surgical treatment, or outcomes in patients undergoing mitral valve surgery at our institution.

Methods: Data were collected from the Cardiovascular Research Database of the Clinical Trial Unit of the Bluhm Cardiovascular Institute at Northwestern Memorial Hospital and they were defined according to the Society of Thoracic Surgeons National Database ( www.sts. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2047487319833307DOI Listing
March 2019
2 Reads

Ayurvedic approach to treat Hridroga (valvular heart disease): A case report.

Authors:
M P Mithra

J Ayurveda Integr Med 2019 Feb 26. Epub 2019 Feb 26.

Department of Indian Systems of Medicine, Kerala, India. Electronic address:

Kabhatika Hridroga (valvular heart disease) embodies a significant part of cardiovascular disease. There are many causes for valvular heart disease of which, the rheumatic fever is an important one. This study is a case report of a patient awaiting mitral valve transplant for valvular heart disease (i. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaim.2018.08.002DOI Listing
February 2019
1 Read

Risk Factors of Atrial Fibrillation in Patients with Heart Failure.

Cureus 2018 Dec 24;10(12):e3774. Epub 2018 Dec 24.

Miscellaneous, National Institute of Cardiovascular Diseases, Karachi, PAK.

Introduction Coexistence of atrial fibrillation (AF) in patients with heart failure (HF) is a common phenomenon associated with poor prognosis. Therefore, this study was designed with an aim to estimate the different risk factors of atrial fibrillation (AF) in patients with HF. Methods In this study, patients of either gender, 18 to 80 years of age, and with echocardiographic confirmation of HF presenting at the adult cardiology department of the National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan were consecutively included. Read More

View Article

Download full-text PDF

Source
https://www.cureus.com/articles/16743-risk-factors-of-atrial
Publisher Site
http://dx.doi.org/10.7759/cureus.3774DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389025PMC
December 2018
4 Reads

Heart valve disease in elderly.

Authors:
Carlo Rostagno

World J Cardiol 2019 Feb;11(2):71-83

Department of Internal Medicine, University of Florence, Florence 50134, Italy.

The incidence of heart valve disease increases significantly with age. Degenerative abnormalities associated with severe aortic stenosis and mitral and tricuspid regurgitation are found in not less than 10% of the population aged ≥ 75 years. Surgical treatment has been considered for years to be the treatment of choice. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4330/wjc.v11.i2.71DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391621PMC
February 2019
3 Reads

A rare case of mitral stenosis: caseous calcification of the mitral annulus.

Kardiol Pol 2019 ;77(2):232

Medical University of Silesia in Katowice, School of Medicine with the Division of Dentistry in Zabrze, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/KP.2019.0021DOI Listing
January 2019
2 Reads

Rheumatic Mitral Valve Stenosis: Diagnosis and Treatment Options.

Curr Cardiol Rep 2019 Feb 28;21(3):14. Epub 2019 Feb 28.

The Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Purpose Of Review: This review provides an update on rheumatic mitral stenosis. Acute rheumatic fever (RF), the sequela of group A β-hemolytic streptococcal infection, is the major etiology for mitral stenosis (MS).

Recent Findings: While the incidence of acute RF in the Western world had substantially declined over the past five decades, this trend is reversing due to immigration from non-industrialized countries where rheumatic heart disease (RHD) is higher. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11886-019-1099-7DOI Listing
February 2019
4 Reads

Clinical, sonographic characteristics and long-term prognosis of valvular heart disease in elderly patients.

J Geriatr Cardiol 2019 Jan;16(1):33-41

Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.

Background: Valvular heart disease (VHD) is expected to become more prevail as the population ages and disproportionately affects older adults. However, direct comparison of clinical characteristics, sonographic diagnosis, and outcomes in VHD patients aged over 65 years is scarce. The objective of this study was to evaluate the differences in clinical characteristics and prognosis in two age-groups of geriatric patients with VHD. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.11909/j.issn.1671-5411.2019.01.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379235PMC
January 2019

Biventricular Repair in Patients With Borderline Left Heart-The "Growing" Experience.

Authors:
Sitaram M Emani

World J Pediatr Congenit Heart Surg 2019 01;10(1):18-19

1 Children's Hospital Boston, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2150135118819418DOI Listing
January 2019
2 Reads

Surgical Outcomes of Biventricular Repair for Hypoplastic Left Ventricle With Congenital Mitral Valve Stenosis.

World J Pediatr Congenit Heart Surg 2019 01;10(1):11-17

1 Department of Pediatric Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

Objective: Surgical outcomes of biventricular repair for hearts with hypoplastic left ventricle with congenital mitral valve stenosis are described. Serial changes of left ventricular geometry and clinical features after biventricular repair were reviewed.

Methods: Eight patients with hypoplastic left ventricle and congenital mitral valve stenosis who underwent first surgical intervention for biventricular circulation in neonatal or infantile period between 2001 and 2014 comprise the study population. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2150135118808748DOI Listing
January 2019
1 Read

Bidirectional flow across a perforate cor triatriatum dexter in a dog with concurrent pulmonary, tricuspid, and mitral valve dysplasia.

J Vet Cardiol 2019 Feb 25;21:93-97. Epub 2019 Jan 25.

Department of Clinical Sciences, Colorado State University, 300 W Drake Rd., Fort Collins, CO 80523, USA.

A 10-week-old male intact mixed breed dog presented for evaluation of suspected right-sided congestive heart failure. Echocardiographic imaging revealed a perforate cor triatriatum dexter (CTD), along with pulmonary valve stenosis and tricuspid and mitral valve dysplasia. In typical CTD cases, there is unidirectional blood flow across the dividing membrane, from the caudal into the cranial right atrial chambers. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvc.2018.12.002DOI Listing
February 2019
2 Reads

Low-Gradient Severe Mitral Stenosis: Hemodynamic Profiles, Clinical Characteristics, and Outcomes.

J Am Heart Assoc 2019 Mar;8(5):e010736

1 Department of Cardiovascular Medicine Mayo Clinic Rochester MN.

Background Optimal management of patients with severe mitral stenosis ( MS ) and low transmitral gradient is incompletely understood. Methods and Results We examined 101 consecutive patients with severe rheumatic MS (mitral valve area ≤1.5 cm) who underwent balloon valvuloplasty. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/JAHA.118.010736DOI Listing
March 2019
6 Reads

Computed tomography as a superior diagnostic test for left atrial thrombus with calcification.

Ann Thorac Surg 2019 Feb 18. Epub 2019 Feb 18.

Department of Cardiovascular Surgery, Yan'an Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, PR China; Cardiovascular Surgery Institution of Yunnan, Kunming, Yunnan, PR China.

Left atrial (LA) thrombus with calcification are rare anomalies in rheumatic mitral stenosis. An accurate preoperative evaluation is critical for making clinical decisions and surgical plans. We report a rheumatic heart disease case presented the exemplary imaging manifestation of massive LA thrombus with calcification. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2019.01.033DOI Listing
February 2019
1 Read

In-Hospital Outcomes of Transcatheter Aortic Valve Implantation in Patients With Mitral Valve Stenosis.

Am J Cardiol 2019 May 8;123(9):1510-1516. Epub 2019 Feb 8.

Cleveland Clinic, Medicine Institute, Cleveland, Ohio.

Little is known about the outcome of patients with mitral stenosis (MS) who underwent transcatheter aortic valve implantation (TAVI). Therefore, we sought to evaluate the potential impact of MS on the outcome of patients who underwent TAVI using the US national cohort. Using weighted data from the National Inpatient Sample database between 2011 and 2015, we identified patients who had undergone a TAVI as a primary procedure. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2019.02.005DOI Listing
May 2019
1 Read

Maternal and Neonatal Complications of Pregnant Women with Mitral Stenosis.

Isr Med Assoc J 2019 Feb;21(2):88-93

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, Israel.

Background: Rheumatic mitral stenosis (MS) is a relatively rare diagnosis in the developed countries and its treatment during pregnancy is challenging due to hemodynamic changes. With the demographic changes due to recent waves of immigration an increase in the prevalence of rheumatic heart disease is expected.

Objectives: To evaluate maternal and neonatal complications in patients with mitral stenosis. Read More

View Article

Download full-text PDF

Source
February 2019
2 Reads

[Isolated Mitral Valve Replacement was Effective in Patient with Hypertrophic Obstructive Cardiomyopathy and Concomitant Mitral Regurgitation;Report of a Case].

Kyobu Geka 2019 Feb;72(2):149-152

Department of Cardiovascular Surgery, Hokuto Hospital, Obihiro, Japan.

This report presents a case of a 68-year-old woman with hypertrophic obstructive cardiomyopathy (HOCM) and concomitant mitral regurgitation (MR). Preoperative echocardiography showed stenosis of the left ventricular outflow tract (LVOT) and systolic anterior leaflet motion (SAM) of the mitral valve. She underwent mitral valve replacement( MVR) alone, and obstruction of LVOT was successfully released. Read More

View Article

Download full-text PDF

Source
February 2019
1 Read

Valve area and the risk of overestimating aortic stenosis.

Heart 2019 Feb 16. Epub 2019 Feb 16.

Department of Cardiology, Hospital General Universitario Gregorio Maranon, Madrid, Spain.

Objective: To obtain reference values of aortic valve area (AVA) in a large population and to infer the risk of overestimating aortic stenosis (AS) when focusing on flow-corrected indices of severity.

Methods: We prospectively measured indices of AS in all consecutive echocardiograms performed in a large referral cardiac imaging laboratory for 1 year. We specifically analysed the distribution of AVA, indexed AVA and velocity ratio (Vratio) in patients with and without AS, the latter defined as the coexistence of valvular outflow obstruction (Vmax ≥2. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/heartjnl-2018-314482DOI Listing
February 2019
1 Read

Contrary to Expectations: Off-Label Transcatheter Aortic Valve Replacement in the Case of Left Ventricular Outflow Tract Obstruction.

Can J Cardiol 2019 Feb 12;35(2):229.e5-229.e6. Epub 2018 Dec 12.

Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

We present the case of a 71-year-old woman who showed recurrent signs of congestive heart failure with the need of rehospitalization after double valve (mitral and aortic) replacement. Extensive diagnostic workup revealed a moderate aortic stenosis and additionally a significant left ventricular outflow tract obstruction. The tissue overgrowth might be attributed to an inflammatory reaction with extensive pannus deposit after aortic valve surgery. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cjca.2018.12.007DOI Listing
February 2019
2 Reads

When a Diuretic Causes Pulmonary Oedema.

Eur J Case Rep Intern Med 2018 26;5(6):000864. Epub 2018 Jun 26.

High Dependency Unit, San Giovanni Bosco Hospital, Torino, Italy.

Background: Hydrochlorothiazide (HCTZ) is one of the most popular drugs for the treatment of hypertension and heart failure. Most of its side effects are harmless and predictable, but some studies report a few life-threatening reactions to this drug, one of the most dangerous being acute pulmonary oedema.

Case Report: A 73-year-old woman was admitted to the Emergency Department with acute respiratory failure due to pulmonary oedema. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12890/2018_000864DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346883PMC
June 2018
1 Read

Outcomes of Transcatheter Aortic Valve Implantation in Patients with Cirrhosis.

Int Heart J 2019 Mar 8;60(2):352-358. Epub 2019 Feb 8.

Department of Cardiology, Sakakibara Heart Institute.

Cirrhosis is a significant adverse factor of cardiac surgeries. Transcatheter aortic valve implantation (TAVI) has evolved as a less invasive therapy for aortic stenosis, whereas detailed case analysis of TAVI in cirrhotic patients is limited.Among 444 consecutive patients who underwent TAVI in the Sakakibara Heart Institute between October 2013 and January 2018, we retrospectively reviewed 11 patients (2. Read More

View Article

Download full-text PDF

Source
https://www.jstage.jst.go.jp/article/ihj/advpub/0/advpub_18-
Publisher Site
http://dx.doi.org/10.1536/ihj.18-339DOI Listing
March 2019
11 Reads

A novel case of late left ventricular outflow tract obstruction post mitral valve surgery.

J Surg Case Rep 2019 Jan 11;2019(1):rjy357. Epub 2019 Jan 11.

Cardiothoracic Surgery, University Hospital Southampton, Southampton, UK.

Left ventricular outflow tract (LVOT) obstruction (LVOTO) is a rare but recognized complication of mitral valve surgery. Concomitant factors can cause significant clinical deterioration which requires urgent intervention. We present the case of a female patient who underwent closed valvotomy at age 20 for mitral stenosis secondary to rheumatic heart disease. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jscr/rjy357DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354753PMC
January 2019
1 Read

Paravalvular leak repair after balloon-expandable transcatheter mitral valve implantation in mitral annular calcification: Early experience and lessons learned.

Catheter Cardiovasc Interv 2019 Feb 9. Epub 2019 Feb 9.

Department of Cardiovascular Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota.

Background: Treatment of hemodynamically significant mitral annular calcification (MAC) using transcatheter approaches is in the early learning phase. The occurrence of paravalvular leak (PVL) following transcatheter mitral valve in MAC is common.

Aims: To report the initial experience and techniques of percutaneous PVL closure after transcatheter valve in MAC. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ccd.28131
Publisher Site
http://dx.doi.org/10.1002/ccd.28131DOI Listing
February 2019
6 Reads